Removing a tumor is tough:
Surgeons may fail to get the entire cancer or may remove too much healthy tissue.
Pending clinical trials in 2018, the MasSpec Pen will allow surgeons to analyze tissue mid-surgery, so all of the bad, and less of the good, is removed.
Source: AARP The Magazine / Real Possibilities Fall Health Special 2017
IF YOU LIKE THESE POSTS, PLEASE CONSIDER CLICKING THE DONATION BUTTON ABOVE. THANK YOU!